Abstract As new GLP-1 weight-loss injections like Ozempic, Wegovy and Mounjaro reshape medicine and culture, Jordan G. Miller, Robert S. Miller, Shawn M. Varney and David Han demonstrate how US poison centres are quietly documenting the growing pains of a pharmaceutical revolution
Miller et al. (Fri,) studied this question.